Trial Profile
Phase III Prospective Multicentric Trial Evaluating Etravirine for HIV Infected Patients in Need of Lipid Lowering Drugs: the ETRALL Trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Oct 2018
Price :
$35
*
At a glance
- Drugs Etravirine (Primary) ; Antiretrovirals; Atazanavir/ritonavir; Darunavir/ritonavir; Efavirenz; Lopinavir/ritonavir
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms ETRALL
- 09 Mar 2012 New trial record